VREX - Varex Imaging Corp
IEX Last Trade
12.47
0.190 1.524%
Share volume: 297,263
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Surgical and Medical Instrument Manufacturing :
-0.56%
PREVIOUS CLOSE
CHG
CHG%
$12.28
0.19
1.55%
View ratios
Fiscal Date | 2022-09-30 | 2022-12-30 | 2023-03-31 | 2023-06-30 | 2023-09-29 | 2023-12-29 | 2024-03-29 | 2024-06-28 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
Report Date | 2022-11-18 | 2023-01-31 | 2023-05-02 | 2023-08-01 | 2023-11-16 | 2024-02-06 | 2024-05-02 | 2024-08-01 | |
Assets | |||||||||
Total Assets | 1.184 B | 1.181 B | 1.191 B | 1.212 B | 1.250 B | 1.242 B | 1.252 B | 1.253 B | |
Current Assets | 609.900 M | 607.300 M | 618.400 M | 638.500 M | 658.300 M | 645.700 M | 651.900 M | 649.300 M | |
Inventories | 303.200 M | 320.300 M | 310.700 M | 297.700 M | 277.500 M | 289.700 M | 286.100 M | 281.700 M | |
Other Current Assets | 44.000 M | 47.600 M | 43.800 M | 59.000 M | 64.600 M | 75.100 M | 25.400 M | 25.600 M | |
Short Term Investments | 44.000 M | 47.600 M | 43.800 M | 59.000 M | 64.600 M | 75.100 M | 25.400 M | 25.600 M | |
Total Receivables | 173.300 M | 157.900 M | 159.500 M | 163.300 M | 163.600 M | 139.600 M | 151.500 M | 152.000 M | |
Current Cash | 89.400 M | 81.500 M | 104.400 M | 118.500 M | 152.600 M | 141.300 M | 188.900 M | 190.000 M | |
Total Non-current Assets | 574.500 M | 573.600 M | 572.400 M | 573.200 M | 591.300 M | 596.600 M | 599.800 M | 603.400 M | |
Property Plant Equipment | 141.300 M | 142.900 M | 142.600 M | 142.000 M | 143.600 M | 148.300 M | 147.700 M | 148.000 M | |
Other Assets | 43.200 M | 39.000 M | 39.100 M | 38.200 M | 37.500 M | 37.100 M | 38.400 M | 39.200 M | |
Intangible Assets | 33.600 M | 31.700 M | 28.900 M | 25.500 M | 22.400 M | 22.100 M | 18.200 M | 16.400 M | |
Goodwill | 284.500 M | 288.200 M | 289.200 M | 289.200 M | 288.500 M | 290.400 M | 289.300 M | 288.900 M | |
Liabilities and shareholders’ equity | |||||||||
Total Liabilities and shareholders’ equity | 1.184 B | 1.181 B | 1.191 B | 1.212 B | 1.250 B | 1.242 B | 1.252 B | 1.253 B | |
Total liabilities | 651.000 M | 669.200 M | 671.200 M | 680.200 M | 681.900 M | 673.400 M | 675.600 M | 671.500 M | |
Total current liabilities | 173.100 M | 157.400 M | 157.200 M | 158.600 M | 162.800 M | 150.100 M | 154.100 M | 194.600 M | |
Accounts Payable | 78.200 M | 86.200 M | 74.200 M | 74.600 M | 64.700 M | 73.700 M | 69.400 M | 69.600 M | |
Other liabilities | 33.800 M | 39.800 M | 42.600 M | 43.700 M | 41.600 M | 44.900 M | 42.100 M | 43.100 M | |
Current long term debt | 2.100 M | 2.100 M | 2.000 M | 1.800 M | 1.500 M | 1.600 M | 1.500 M | 46.200 M | |
Long term debt | 412.300 M | 440.800 M | 441.000 M | 441.100 M | 441.100 M | 441.400 M | 441.400 M | 396.900 M | |
Other liabilities | 33.800 M | 39.800 M | 42.600 M | 43.700 M | 41.600 M | 44.900 M | 42.100 M | 43.100 M | |
Minority interest | 13.300 M | 13.300 M | 13.300 M | 13.400 M | 13.300 M | 14.100 M | 14.100 M | 14.100 M | |
Total Shareholder equity | 533.400 M | 511.700 M | 519.600 M | 531.500 M | 567.700 M | 568.900 M | 576.100 M | 581.200 M | |
Common stock | 40.100 M | 40.100 M | 40.200 M | 40.400 M | 40.500 M | 40.600 M | 40.700 M | 40.900 M | |
Retained earnings | 63.800 M | 73.300 M | 77.400 M | 86.500 M | 118.100 M | 117.500 M | 119.000 M | 120.400 M |